human-papillomavirus

Documents about human-papillomavirus

• Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides#874538ClinicalTrials.gov
• Real-world Study of First Line Pembrolizumab- or Nivolumab-treated HPV-positive Recurrent/Metastatic Oropharyngeal Squamous Cell Carcinoma#863188ClinicalTrials.gov
• Sexually Transmitted Infections Among African American Women Who Have Sex With Women#893917ClinicalTrials.gov
• Multicenter Prospective Non-randomized Controlled Study of ALA-PDT for LSIL With HPV16/18 Infection#1009668ClinicalTrials.gov
• The Cervicovaginal Microbiota and Its Associations With Human Papillomavirus Detection in HIV-Infected and HIV-Uninfected Women#624328eScholarship
• Association of cervical precancer with human papillomavirus types other than 16 among HIV co-infected women#814597eScholarship
• BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer#838353ClinicalTrials.gov
• A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males#881431ClinicalTrials.gov
• Immunogenicity and Safety of the Quadrivalent Human Papillomavirus Vaccine in HIV-1–Infected Women#642151eScholarship
• Clinical Evaluation of Detection of High Risk HPV in Urine#969743ClinicalTrials.gov
• A Study to Evaluate the Immunogenicity, Safety and Tolerability of Quadrivalent Human Papillomavirus Vaccine (V501) in Chinese Girls Aged 9-19 Years and Young Women Aged 20-26 Years (V501-213)#272428ClinicalTrials.gov
• Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck#878842ClinicalTrials.gov
• A Study of HB-202/HB-201 With Pembrolizumab in Patients With HPV16+ Recurrent/Metastatic Oropharyngeal Cancer#993319ClinicalTrials.gov
• Evaluation Of The Efficacy Of The Combination Of GLIZIGEN® Oral Solution 1/Day And Vaginal Gel 1/Night For 2 Months In Patients With Cervical Intraepithelial Neoplasia Grade 1 (LSIL/CIN-1) Caused By High-Risk Human Papillomavirus (HPV-AR)#846841ClinicalTrials.gov
• Human papillomavirus knowledge, vaccine acceptance, and vaccine series completion among female entertainment and sex workers in Phnom Penh, Cambodia: the Young Women’s Health Study#683959eScholarship
• Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squamous Cell Carcinoma#290974ClinicalTrials.gov
• Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer#878762ClinicalTrials.gov
• Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial#873753ClinicalTrials.gov